Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Equity Ratio (2016 - 2025)

Abeona Therapeutics has reported Equity Ratio over the past 15 years, most recently at 0.73 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.73 for Q4 2025, up 79.39% from a year ago — trailing twelve months through Dec 2025 was 0.73 (up 79.39% YoY), and the annual figure for FY2025 was 0.73, up 79.39%.
  • Equity Ratio for Q4 2025 was 0.73 at Abeona Therapeutics, down from 0.74 in the prior quarter.
  • Over the last five years, Equity Ratio for ABEO hit a ceiling of 0.74 in Q3 2025 and a floor of 0.12 in Q1 2024.
  • Median Equity Ratio over the past 5 years was 0.41 (2024), compared with a mean of 0.44.
  • Biggest five-year swings in Equity Ratio: tumbled 133.78% in 2024 and later soared 451.02% in 2025.
  • Abeona Therapeutics' Equity Ratio stood at 0.53 in 2021, then dropped by 21.72% to 0.42 in 2022, then tumbled by 44.41% to 0.23 in 2023, then skyrocketed by 74.49% to 0.4 in 2024, then surged by 79.39% to 0.73 in 2025.
  • The last three reported values for Equity Ratio were 0.73 (Q4 2025), 0.74 (Q3 2025), and 0.66 (Q2 2025) per Business Quant data.